Carls John de Tomas fails anti-doping test
The UFC organization was notified today that the U.S. Anti-Doping Agency (USADA) has informed Carls John de Tomas of a potential Anti-Doping Policy violation.
Philippines-based former UFC bantamweight Carls John de Tomas has failed an anti-doping test. The news comes via UFC.com.
The UFC organization was notified today that the U.S. Anti-Doping Agency (USADA) has informed Carls John de Tomas of a potential Anti-Doping Policy violation stemming from an in-competition sample collected following his weigh-in on December 8, 2017.
Although de Tomas is no longer under contract with UFC, USADA, the independent administrator of the UFC Anti-Doping Policy, will handle the results management and appropriate adjudication of this case, as it relates to the UFC Anti-Doping Policy. Under the UFC Anti-Doping Policy, there is a full and fair legal process that is afforded to all athletes before any sanctions are imposed. The California State Athletic Commission (CSAC) also retains jurisdiction over this matter as the sample collection was performed the day before de Tomas’ bout at UFC Fight Night: Swanson vs Ortega in Fresno, CA. Accordingly, USADA will work to ensure that the CSAC has the necessary information to determine its proper judgment of de Tomas’ potential anti-doping violation.
Additional information will be provided at the appropriate time as the process moves forward.
The fighter went a perfect 8-0 in his home nation, but came up short in the big show, losing via Unanimous Decision to Naoki Inoue at UFC Fight Night 111 and via submission to Alex Perez at UFC Fight Night 123 earlier this month. At only 21 years old, he still has a bright future ahead.
While there is some reason to think that PEDs were a major problem in MMA prior to USADA and remain a major problem outside the UFC, every fighter with a flagged test is not guilty of PED use.For example, in a little over a year, Ning Guangyou, Li Jingliang, Augusto Montano, and Brandon Moreno each was flagged for Clenbuterol, but eventually found No Fault due to the ubiquity of trace elements of Clenbuterol in the food chain in Mexico and China. As noted, de Tomas will be subject to a fair investigation, with full details becoming known in time.
